SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048455823> ?p ?o ?g. }

Showing items 1 to 100 of ±114 with 100 items per page.

W3048455823 endingPage "219" @default.
W3048455823 startingPage "214" @default.
W3048455823 abstract "Background Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is a mitochondrial fatty acid oxidation disorder that causes episodic attacks, such as general fatigue, hypotonia, myalgia, and rhabdomyolysis accompanied by lack of energy. As yet, there are no preventative drugs for these VLCADD-associated metabolic attacks. Patients and methods We conducted an open-label, non-randomized, multi-center study into the effects of bezafibrate on five patients with VLCADD. Bezafibrate was administered for 4 years, and we analyzed the number of myopathic attacks requiring hospitalization and treatment infusions. Results The number of myopathic attacks requiring infusions of 24 h or longer significantly decreased during the study period. The patients’ ability to conduct everyday activities was also improved by the treatment. Conclusion Our findings show the potential long-term efficacy of bezafibrate in preventing myopathic attacks for patients with VLCADD." @default.
W3048455823 created "2020-08-18" @default.
W3048455823 creator A5003002099 @default.
W3048455823 creator A5013344739 @default.
W3048455823 creator A5015906898 @default.
W3048455823 creator A5021567238 @default.
W3048455823 creator A5034547906 @default.
W3048455823 creator A5039826795 @default.
W3048455823 creator A5042674767 @default.
W3048455823 creator A5044539242 @default.
W3048455823 creator A5045329864 @default.
W3048455823 creator A5047388069 @default.
W3048455823 creator A5048873944 @default.
W3048455823 creator A5067658265 @default.
W3048455823 creator A5071659779 @default.
W3048455823 creator A5076942536 @default.
W3048455823 creator A5078000437 @default.
W3048455823 creator A5079822470 @default.
W3048455823 creator A5079948261 @default.
W3048455823 creator A5080530083 @default.
W3048455823 creator A5081770697 @default.
W3048455823 creator A5089481856 @default.
W3048455823 creator A5089768085 @default.
W3048455823 date "2021-02-01" @default.
W3048455823 modified "2023-10-16" @default.
W3048455823 title "Efficacy of bezafibrate for preventing myopathic attacks in patients with very long-chain acyl-CoA dehydrogenase deficiency" @default.
W3048455823 cites W1897229149 @default.
W3048455823 cites W1934325817 @default.
W3048455823 cites W1972881249 @default.
W3048455823 cites W2022181207 @default.
W3048455823 cites W2028679249 @default.
W3048455823 cites W2040991550 @default.
W3048455823 cites W2061209871 @default.
W3048455823 cites W2092815717 @default.
W3048455823 cites W2101428367 @default.
W3048455823 cites W2113328569 @default.
W3048455823 cites W2149496263 @default.
W3048455823 cites W2168580423 @default.
W3048455823 cites W2512202260 @default.
W3048455823 cites W2790104756 @default.
W3048455823 cites W2803304886 @default.
W3048455823 cites W2913907150 @default.
W3048455823 cites W2957790756 @default.
W3048455823 doi "https://doi.org/10.1016/j.braindev.2020.07.019" @default.
W3048455823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32798077" @default.
W3048455823 hasPublicationYear "2021" @default.
W3048455823 type Work @default.
W3048455823 sameAs 3048455823 @default.
W3048455823 citedByCount "4" @default.
W3048455823 countsByYear W30484558232022 @default.
W3048455823 countsByYear W30484558232023 @default.
W3048455823 crossrefType "journal-article" @default.
W3048455823 hasAuthorship W3048455823A5003002099 @default.
W3048455823 hasAuthorship W3048455823A5013344739 @default.
W3048455823 hasAuthorship W3048455823A5015906898 @default.
W3048455823 hasAuthorship W3048455823A5021567238 @default.
W3048455823 hasAuthorship W3048455823A5034547906 @default.
W3048455823 hasAuthorship W3048455823A5039826795 @default.
W3048455823 hasAuthorship W3048455823A5042674767 @default.
W3048455823 hasAuthorship W3048455823A5044539242 @default.
W3048455823 hasAuthorship W3048455823A5045329864 @default.
W3048455823 hasAuthorship W3048455823A5047388069 @default.
W3048455823 hasAuthorship W3048455823A5048873944 @default.
W3048455823 hasAuthorship W3048455823A5067658265 @default.
W3048455823 hasAuthorship W3048455823A5071659779 @default.
W3048455823 hasAuthorship W3048455823A5076942536 @default.
W3048455823 hasAuthorship W3048455823A5078000437 @default.
W3048455823 hasAuthorship W3048455823A5079822470 @default.
W3048455823 hasAuthorship W3048455823A5079948261 @default.
W3048455823 hasAuthorship W3048455823A5080530083 @default.
W3048455823 hasAuthorship W3048455823A5081770697 @default.
W3048455823 hasAuthorship W3048455823A5089481856 @default.
W3048455823 hasAuthorship W3048455823A5089768085 @default.
W3048455823 hasBestOaLocation W30484558231 @default.
W3048455823 hasConcept C126322002 @default.
W3048455823 hasConcept C134018914 @default.
W3048455823 hasConcept C181199279 @default.
W3048455823 hasConcept C185592680 @default.
W3048455823 hasConcept C2776317432 @default.
W3048455823 hasConcept C2776362216 @default.
W3048455823 hasConcept C55493867 @default.
W3048455823 hasConcept C71924100 @default.
W3048455823 hasConcept C90924648 @default.
W3048455823 hasConceptScore W3048455823C126322002 @default.
W3048455823 hasConceptScore W3048455823C134018914 @default.
W3048455823 hasConceptScore W3048455823C181199279 @default.
W3048455823 hasConceptScore W3048455823C185592680 @default.
W3048455823 hasConceptScore W3048455823C2776317432 @default.
W3048455823 hasConceptScore W3048455823C2776362216 @default.
W3048455823 hasConceptScore W3048455823C55493867 @default.
W3048455823 hasConceptScore W3048455823C71924100 @default.
W3048455823 hasConceptScore W3048455823C90924648 @default.
W3048455823 hasFunder F4320311405 @default.
W3048455823 hasIssue "2" @default.
W3048455823 hasLocation W30484558231 @default.
W3048455823 hasOpenAccess W3048455823 @default.
W3048455823 hasPrimaryLocation W30484558231 @default.
W3048455823 hasRelatedWork W115077256 @default.